MPS Pharmaa Limited (BOM:531686)

Market Cap	33.06M +394.3%
Revenue (ttm)	204.00 -100.0%
Net Income	-9.40M
EPS	-0.50
Shares Out	19.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	985
Open	1.730
Previous Close	1.730
Day's Range	1.730 - 1.730
52-Week Range	1.570 - 3.010
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About MPS Pharmaa

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 18
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531686

Financial Performance

In fiscal year 2025, MPS Pharmaa's revenue was 477,204, a decrease of -49.05% compared to the previous year's 936,669. Losses were -8.98 million, 8.05% more than in 2024.